US Drug Recall Register
Class III · Low risk Terminated Initiated Sep 9, 2015 (11 years ago)

Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent Drug

What was recalled

Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (contains 5 single dose vials of Bravelle, 5 single dose vials of 0.9% Sodium Chloride Inj., USP, 2 mL, and 5 Q-Cap Vial Adaptors) , Rx Only, Manufactured for: Ferring Pharmaceuticals, Inc. Parsippany, NJ 07054, By: Ferring Gmbh, Kiel Germany, NDC 55566-8505-6

Recalling firm
Ferring Pharmaceuticals Inc
NDC code
55566-8505-6
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0015-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all